Fed Circuit opens door for additional pharma revenues in Supernus decision

24-01-2019

Fed Circuit opens door for additional pharma revenues in Supernus decision

olm26250 / iStockphoto.com

The US Court of Appeals for the Federal Circuit has overturned a reduction in the patent term adjustment (PTA) owned by Supernus Pharmaceuticals.


Supernus Pharmaceuticals, US Court of Appeals for the Federal Circuit, patent term adjustment, Sandoz, patent litigation, pharmaceuticals

WIPR